LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $604,000 | -9.6% | 6,066 | +3.7% | 0.67% | -9.5% |
| Q2 2019 | $668,000 | -9.7% | 5,848 | -0.7% | 0.74% | -14.1% |
| Q1 2019 | $740,000 | -8.4% | 5,889 | -1.1% | 0.86% | -13.3% |
| Q4 2018 | $808,000 | -57.4% | 5,955 | -13.8% | 0.99% | -47.0% |
| Q3 2018 | $1,895,000 | +33.3% | 6,905 | +0.6% | 1.87% | +18.3% |
| Q2 2018 | $1,422,000 | +25.4% | 6,865 | 0.0% | 1.58% | +28.6% |
| Q1 2018 | $1,134,000 | +22.6% | 6,865 | +1.6% | 1.23% | +25.8% |
| Q4 2017 | $925,000 | -2.4% | 6,755 | -3.0% | 0.98% | -0.8% |
| Q3 2017 | $948,000 | – | 6,965 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |